Market revenue in 2023 | USD 183.3 million |
Market revenue in 2030 | USD 337.4 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.39% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is the fastest-growing market, as many developed economies are outsourcing clinical trials to countries such as China, India, and South Korea. Furthermore, due to the large & diverse patient pools available in these countries, recruitment for clinical trials is increasing in Asia Pacific compared to North America & Europe.
Developed clinical research infrastructure, a strong hospital network, and the availability of skilled medical practitioners are further supporting the growth of the Asia Pacific market.
The local presence of multinational pharmaceutical/biopharmaceutical companies & CROs in the region and the higher cost-efficiency of conducting clinical trials compared to the U.S. and European countries are creating growth opportunities in the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical trial patient recruitment services market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account